- Home
- STNG vs APLS Comparison
STNG vs APLS Comparison
Compare STNG & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | STNG | APLS |
|---|---|---|
| Founded | 2009 | 2009 |
| Country | Monaco | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 2.7B |
| IPO Year | 2010 | 2017 |
Fundamental Metrics
Financial Performance| Metric | STNG | APLS |
|---|---|---|
| Price | $52.18 | $25.03 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 19 |
| Target Price | ★ $69.20 | $33.11 |
| AVG Volume (30 Days) | 1.0M | ★ 2.2M |
| Earning Date | 10-30-2025 | 10-30-2025 |
| Dividend Yield | ★ 3.23% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 5.88 | 0.36 |
| Revenue | $889,539,000.00 | ★ $1,016,397,000.00 |
| Revenue This Year | N/A | $29.00 |
| Revenue Next Year | $1.54 | N/A |
| P/E Ratio | ★ $9.05 | $70.45 |
| Revenue Growth | N/A | ★ 42.11 |
| 52 Week Low | $30.63 | $16.10 |
| 52 Week High | $65.52 | $35.71 |
Technical Indicators
Market Signals| Indicator | STNG | APLS |
|---|---|---|
| Relative Strength Index (RSI) | 26.32 | 67.89 |
| Support Level | $55.40 | $23.54 |
| Resistance Level | $57.50 | $25.52 |
| Average True Range (ATR) | 1.66 | 0.92 |
| MACD | -0.64 | 0.61 |
| Stochastic Oscillator | 2.20 | 92.36 |
Price Performance
Historical ComparisonAbout STNG Scorpio Tankers Inc.
Scorpio Tankers Inc is a provider of marine transportation of petroleum products. It owned, lease financed, or chartered in vessels spanning three different vessel segments Handymax, MR, and LR2. The company's fleet of tankers is the eco-friendly, and newest fleet on the water hauling clean petroleum products. It provides seaborne transportation of crude oil and refined petroleum products. The company generates the majority of its revenue from LR2.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.